Randomized Trial Comparing SGLT2 Inhibition and Hydrochlorothiazide on Sympathetic Traffic in Type 2 Diabetes

INTRODUCTION: Reductions in sympathetic nervous system activity may contribute to beneficial effects of sodium glucose cotransporter 2 (SGLT2) inhibition on cardiovascular outcomes. Therefore, we tested the hypothesis that SGLT2 inhibition with empagliflozin (Empa) lowers muscle sympathetic nerve ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Heusser, Karsten, Tank, Jens, Diedrich, André, Fischer, Annelie, Heise, Tim, Jordan, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658269/
https://www.ncbi.nlm.nih.gov/pubmed/38025218
http://dx.doi.org/10.1016/j.ekir.2023.08.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658269/
https://www.ncbi.nlm.nih.gov/pubmed/38025218
http://dx.doi.org/10.1016/j.ekir.2023.08.036

Ejemplares similares